Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
Bladé J, San Miguel JF, Fontanillas M, Esteve J, Maldonado J, Alcalá A, Brunet S, García-Conde J, Besalduch J, Moro MJ, Fernández-Calvo J, Conde E, Font L, Gardella S, Carnero M, Carbonell F, Martí JM, Hernández-Martín J, Ortega F, Besses C, Ribera JM, Trujillo J, Escudero ML, Rozman C, Estapé J, Montserrat E. Bladé J, et al. Among authors: trujillo j. Hematol J. 2001;2(4):272-8. doi: 10.1038/sj.thj.6200115. Hematol J. 2001. PMID: 11920260 Clinical Trial.
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
Bladé J, Rosiñol L, Sureda A, Ribera JM, Díaz-Mediavilla J, García-Laraña J, Mateos MV, Palomera L, Fernández-Calvo J, Martí JM, Giraldo P, Carbonell F, Callís M, Trujillo J, Gardella S, Moro MJ, Barez A, Soler A, Font L, Fontanillas M, San Miguel J; Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA). Bladé J, et al. Among authors: trujillo j. Blood. 2005 Dec 1;106(12):3755-9. doi: 10.1182/blood-2005-03-1301. Epub 2005 Aug 16. Blood. 2005. PMID: 16105975 Free article. Clinical Trial.
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
Bladé J, San Miguel JF, Fontanillas M, Alcalá A, Maldonado J, García-Conde J, Conde E, Conzález-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estapé J, Montserrat E. Bladé J, et al. Among authors: trujillo j. J Clin Oncol. 1996 Jul;14(7):2167-73. doi: 10.1200/JCO.1996.14.7.2167. J Clin Oncol. 1996. PMID: 8683251 Clinical Trial.
Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma.
Hernández JM, García-Sanz R, Golvano E, Bladé J, Fernandez-Calvo J, Trujillo J, Soler JA, Gardella S, Carbonell F, Mateo G, San Miguel JF. Hernández JM, et al. Among authors: trujillo j. Br J Haematol. 2004 Oct;127(2):159-64. doi: 10.1111/j.1365-2141.2004.05186.x. Br J Haematol. 2004. PMID: 15461621 Free article. Clinical Trial.
Antihormone treatment of stage IV breast cancer.
Manni A, Trujillo JE, Marshall JS, Brodkey J, Pearson OH. Manni A, et al. Among authors: trujillo je. Cancer. 1979 Feb;43(2):444-50. doi: 10.1002/1097-0142(197902)43:2<444::aid-cncr2820430207>3.0.co;2-c. Cancer. 1979. PMID: 421171
Comment on: Matsumoto et al.
Cremin M, Hurley S, Trujillo J. Cremin M, et al. Among authors: trujillo j. Clin Transl Allergy. 2024 Nov;14(11):e70000. doi: 10.1002/clt2.70000. Clin Transl Allergy. 2024. PMID: 39520674 Free PMC article. No abstract available.
744 results